Trials / Conditions / Transplant-Related Disorder

Transplant-Related Disorder

23 registered clinical trials studyying Transplant-Related Disorder — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML NCT07157514	Actinium Pharmaceuticals	Phase 2 / Phase 3
Recruiting	A Cohort Study on the Association Between the ANS Function and Acute GvHD NCT07374874	Institute of Hematology & Blood Diseases Hospital, China	—
Recruiting	Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Al NCT07013370	Antonello Di Paolo, M.D., Ph.D.	—
Not Yet Recruiting	Optimal Timing of Hepatitis B Vaccination After Transplants NCT06888479	Institute of Hematology & Blood Diseases Hospital, China	Phase 3
Recruiting	Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients NCT06066957	University of Pennsylvania	Phase 2
Recruiting	Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant NCT06950788	University of Chicago	—
Recruiting	Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstituti NCT06208137	Institute of Hematology & Blood Diseases Hospital, China	N/A
Terminated	Treatment Chronic UTI Post Kidney Transplant NCT05967130	Shahid Beheshti University of Medical Sciences	Phase 3
Active Not Recruiting	Quantra® System With the QPlus® Cartridge in Double-lung Transplantation NCT05798286	Hopital Foch	N/A
Unknown	Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model NCT05599256	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Completed	Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model NCT05600855	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Unknown	Neuropsychological and Biopsychosocial Evolution During Pediatric Transplantation: Pre/Post-stages and at 6 Mo NCT05441436	Hospital Universitario La Paz	—
Completed	EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTS NCT05629923	University of Rome Tor Vergata	—
Completed	Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant NCT04985409	Cedars-Sinai Medical Center	N/A
Unknown	N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. NCT04756622	moshe yeshurun	Phase 3
Withdrawn	Liver Transplantation: Skeletal Effects NCT03399227	Medical University of Vienna	—
Completed	Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation NCT03769441	University Medical Center Groningen	Phase 3
Completed	Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates NCT03811873	Mayo Clinic	N/A
Completed	Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients NCT03636412	The Cleveland Clinic	N/A
Unknown	Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial) NCT03015012	Western University, Canada	N/A
Completed	Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT NCT03448679	Medical University of Vienna	—
Terminated	Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclopho NCT02434146	University of Wisconsin, Madison	Phase 1 / Phase 2
Available	Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use) NCT06393660	Victor Aquino	—